Autologous serum therapy in chronic urticaria: Old wine in a new bottle | Zendy

AK Bajaj | Zendy; Abir Saraswat | Zendy; Amitabh Kumar Upadhyay | Zendy; Rajetha Damisetty | Zendy; Sandipan Dhar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Autologous serum therapy in chronic urticaria: Old wine in a new bottle

Author(s) -

AK Bajaj,

Abir Saraswat,

Amitabh Kumar Upadhyay,

Rajetha Damisetty,

Sandipan Dhar

Publication year - 2008

Publication title -

indian journal of dermatology venereology and leprology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.514

H-Index - 45

eISSN - 0973-3922

pISSN - 0378-6323

DOI - 10.4103/0378-6323.39691

Subject(s) - medicine , asymptomatic , group b , gastroenterology , surgery , chronic urticaria , cohort

Chronic urticaria (CU) is one of the most challenging and frustrating therapeutic problems faced by a dermatologist. A recent demonstration of abnormal type 1 reactions to intradermal autologous serum injections in some CU patients has led to the characterization of a new subgroup of "autoimmune chronic urticaria". This has rekindled interest in the age-old practice of autologous blood injections as a theoretically sound treatment option in these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research